Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel, Carboplatin, and Etoposide in High Grade Neuroendocrine Carcinoma
NCT00193531Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Dec 1998
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in neuroendocrine carcinoma (NEC), sponsored by SCRI Development Innovations. Started Dec 1998; status: completed.
02
Drugs
paclitaxel
03
Conditions
neuroendocrine carcinoma (NEC)
Beyond the preview
Go deeper on NCT00193531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193531.